Fig. 2From: Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trialTime to death in participants with vHABP (ITT population). C/T, ceftolozane/tazobactam. ITT, intention to treat population (all randomized patients). vHABP, ventilated hospital-acquired bacterial pneumoniaBack to article page